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Aim.To investigate the relationship between the effects of electroacupuncture/moxibustion and the balance ofTh17/Treg in treating
ulcerative colitis (UC) and to preliminary compare the effects of the above two methods. Methods. DSS-induced UC mice were
treated by electroacupuncture and moxibustion. Disease activity index (DAI) was scored; intestinal pathological structure and
ultrastructure were observed. The levels of IL-2, IL-6, IL-10, IL-17A, IL-17F, and TGF-𝛽 in plasma were measured by ELISA. The
percentages of Treg andTh17 in spleen lymphocytes were analyzed by flow cytometry. Also, the expressions of TLR2, TLR4, ROR𝛾t,
and FOXP3 in the distal colon were detected by immunohistochemistry or western blot. Results. Both electroacupuncture and
moxibustion can relieve UC.These effects are further supported by ELISA results. In addition, the ratio of Treg andTh17 in spleen
lymphocytes and the expression of TLR2 and TLR4 are significantly improved. Also, the expression of ROR𝛾t and FOXP3 in distal
colon were improved. Besides, the effect of moxibustion is better than that of electroacupuncture on TLR2, TLR4, and FOXP3
expression (𝑃 < 0.05). Conclusion. Both electroacupuncture and moxibustion may ameliorate UC by regulating the balance of
Th17/Treg. Whether moxibustion has better efficacy than electroacupuncture needs further study.
1. Introduction
Ulcerative colitis (UC) is a common kind of chronic colonic
inflammation disease in north America and northern Europe
with incidence varying from nine to twenty cases per one
hundred thousand person-years [1]. A population-based
cohort study proved that despite an overall normal life
expectancy for patients with ulcerative colitis, patients >50
years of age and with extensive colitis at diagnosis had
increased mortality within the first 2 years after diagnosis.
Therefore, it is very important to control the disease pro-
gression [2]. In addition, with the increasing adoption of
industrialized lifestyle, the incidence of UC has increased
in developing country such as China [3]. Therefore, the
management of UC is very critical worldwide.
The primary symptoms of UC are abdominal pain,
diarrhea, bloody stool, and weight loss [4, 5]. The causes
that can induce UC are many, such as genetic, infection,
immunity, and environment to name a few. While previous
studies have shown thatTh1/Th2may play a crucial role in the
production of UC [6], recent studies however have found that
CD4+ T cell subsets Treg and Th17 form a new immune axis
and are closely related to the occurrence and development
of UC [6–8]. First of all, Treg cells orchestrate the overall
immune response and play important roles in preventing the
aggravation of UC by regulating the activity of effect T cells.
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It suppresses the activity of effect cells by secreting TGF-𝛽1
and/or IL-10 which inhibit the proliferation of Th cells and
their production of inflammatory factor [9]. On the other
hand, Th17 cells, as a key effecter in the immune response,
play critical roles in the development of autoimmunity by
producing IL-17 and other proinflammatory cytokines such
as IL-6, IL-21, IL-22, and TNF-𝛼, which in turn induce the
migration of neutrophils towards sites of infection to elicit an
inflammatory response [7, 10, 11]. Many studies, so far, have
shown that these two kinds of cells form an immune balance
as a switch of a variety of immune diseases including UC [12].
Conventional drugs for UC include aminosalicylates,
corticosteroids, antibiotics, and immunomodulators [13].
However, side effects such as nausea, vomiting, headaches,
rash, fever, agranulocytosis, pancreatitis, nephritis, hepati-
tis, and male infertility have been widely reported using
these drugs [14]. As a result, complementary and alternative
medicine may play an important role in dealing with UC
without causing any one of the aforementioned side effects
[15]. For instance, many patients, especially in China and
Asia areas, try to consult traditional medical doctors to
manage their conditions by acupuncture and moxibustion
[16]. Up till now, reports have demonstrated that acupuncture
plus moxibustion or moxibustion alone can (1) manage the
symptoms of abdominal pain, diarrhea, bloody stool, and
consequentweight loss [17], (2) promote recovery of damaged
intestinal tissues due to inflammation [18], and (3) suppress
the inflammatory response of UC [19]. However, as to the
Th17/Treg, so far very few studies of acupuncture and moxi-
bustion have direct evidence to show that they can influence
the balance of these two kinds of cells. What is more, study
which directly compared the effect of acupuncture with that
of moxibustion for treating UC is lacking. Therefore, in
this study, we will design the animal study so as to attest
if acupuncture and moxibustion can ameliorate UC and
whether their effects are obtained from improving the balance
of Th17/Treg. In addition, we will also compare the effects of
acupuncture and moxibustion to see which one is better in
alleviating UC based on animal experiment.
2. Materials and Methods
2.1. Ethics Statement. All experimental animals were pur-
chased from Laboratory Animal Services Center of Sichuan
Provincial People’sHospital (Sichuan,China). All experimen-
tal procedures were approved by the Animal Care and Use
Committee of Chengdu University of Traditional Chinese
Medicine.
2.2. Animals and UC Model Inducing. Male Kun Ming mice
(36±2 g, 6–8 weeks) were housed in an environmentally con-
trolled vivarium under a 12 h light–dark cycle (temperature
20 ± 2∘C, humidity 50–60%). Food and water were available
ad libitum. After 1 week’s adaptation, the mice were divided
into 4 groups randomly; among them, three groups were
induced to ulcerative colitis model by drinking 3% Dextran
Sodium Sulfate (DSS, 43 kDa, MP Biomedicals) [20]. The
control group received ordinary water only. After successful
setting of the model, the UC model mice were randomly
divided intoUCmodel group, electroacupuncture group, and
moxibustion group.
2.3. Electroacupuncture and Moxibustion Treatment. From
the 5th day of modeling, treatments were performed. In
the electroacupuncture group, acupoints “Guanyuan” (RN4)
and “Zusanli” (ST36) were considered to be effective in
treating UC according to clinic practice [21] and our previous
studies [22, 23]. Acupoints “Guanyuan” (RN4) and “Zusanli”
(ST36) were chosen for their effectiveness in improving
the symptoms of UC human patients [21–23]. The right
and left acupoints of ST36 will be used alternately. The
locations for these acupoints were determined according
to Government Channel and Points Standard GB12346-
90 of China and “The Veterinary Acupuncture of China.”
One-channel electrical stimulations were performed via the
two stainless-steel acupuncture needles (Ø 0.25 × 0.25mm)
being inserted into the acupoints with a pulse generator
(Model 1002378080; China Medical Supplies Factory Co.,
Ltd., Suzhou, China). The electrical stimuli consisted of
pulse trains with a frequency range from 2 to 100Hz with
dilatational wave and voltage range from 2 to 4V.The current
is 0.1mA.Themoxa stick (diameter 0.5 cm, length 15 cm) was
ignited and hung 1.5 cm above acupoints RN4 and ST36. Each
acupoint was used in the treatment for 10min every day. The
whole treatment course comprised 5 days.
2.4. Sample Collection. Body weight was measured every
day. Occult blood tests were used to evaluate the UC
symptom. After five days of treatment, all animals were
anesthetizedwith 1%pentobarbital sodiumat a concentration
of 3ml/kg. One-milliliter blood samples were collected by
eyeball removal into a heparin tube. Spleens were removed,
fromwhich lymphocytes were collected and centrifuged, and
single cell suspensions of splenocytes were stimulated and
detected by flow cytometry. The distal colon tissues from
mice were either embedded in paraffin blocks and sectioned,
or fixed in formaldehyde, or frozen in liquid nitrogen and
subsequently stored at −80∘C for later western blot test.
2.5. Disease Activity Evaluation of UC Mice. The mice were
observed daily for morbidity and given a clinical disease
score (disease activity index, DAI) between 0 and 15 based
on the following characteristic criteria: body weight loss,
characteristics of feces, and fecal occult blood (Table 1). The
DAI is expressed as the equation: DAI = (body weight loss +
characteristics of feces + fecal occult blood)/3 [24].
2.6. Histological Observation. The distal colonic tissue (2 cm
beyond the anus, the total segment length being about
4 cm) was fixed and paraffin-embedded and stained with
hematoxylin and eosin (H&E) to allow histological examina-
tion. We further observed the morphology of distal colonic
mucosal epithelia by electron microscopy.
2.7. ELISA Assay. The levels of IL-6, IL-10, IL-17A, IL-17F,
and transforming growth factor 𝛽 (TGF-𝛽) in blood were
detected by typical enzyme-linked immunosorbent assay
(ELISA) with commercially available kits (Shanghai Blue
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Table 1: Ulcerative colitis disease activity index.
Body weight loss (%) Characteristics of feces Fecal occult blood/gross fecal blood Scoring
0 Normal Normal 0
1–5 Loose Fecal occult blood 1
6–10 Loose Fecal occult blood 2
11–15 Watery feces Naked eye bloody feces 3
>16 Watery feces Naked eye bloody feces 4
Gene Biotech Co., Ltd., China), according to the manufac-
turer’s protocol.
2.8. Immunohistochemical Staining and Semiquantitative
Analysis. To evaluate the serious degree of inflammation,
the expressions of the toll-like receptors (TLR2 and TLR4,
bought from Abcam Inc., USA) were detected in the colon
tissue by the immunohistochemical method. Briefly, colonic
tissues were fixed in 4.0% buffered paraformaldehyde and
paraffin-embedded. 5𝜇m thick sections were taken from the
paraffin blocks and the immunohistochemical studies were
performed on this section. 3.0%bovine serumalbumin (BSA)
was used for 1 h to reduce nonspecific antibody binding. The
slides were incubated overnight at 4∘C with mouse TLR2
and TLR4 antibodies (dilution 1 : 200). Secondary antibody
and streptavidin biotinylated tests were performed later.
All the immunohistochemical slides were semiquantitatively
analyzed and interpreted by two researchers blinded to the
treatment. Five random fields at 400x magnification were
counted in each sectioned sample.The relative optical density
was quantified by the Image-Pro Plus 6.0 (MediaCybernetics,
USA).
2.9. Flow Cytometry. The spleen lymphocytes were
collected and centrifuged, and single cell suspensions
of splenocytes were stimulated. For Treg analysis, FITC (BD
Biosciences, USA), PE (BD Biosciences, USA), and Foxp3
PerCP-cy5.5 (eBioscience, USA) were used for dying
CD4+CD25+Foxp3+Treg cells and their corresponding
isotype controls. For Th17 analysis, lymphocytes from spleen
of each group were stimulated with ionomycin, PMA,
and monensin for 5 h. FITC, PE, and IL-17A PerCP-cy5.5
(eBioscience, USA) were used for dying CD3+CD8+IL-
17+Th17 cells and their respective isotype controls (from BD
Biosciences, USA, and eBioscience, USA, resp.). Then, the
single cell suspensions of splenocytes were incubated and
washed. The levels of Treg and Th17 cytokines in the spleen
lymphocytes were detected by flow cytometry (FC-500, Beck
Coulter, USA).
2.10. Western Blot. Protein extracts were prepared from
the distal colon tissues using a lysis buffer supplemented
with ethylenediaminetetraacetic acid- (EDTA-) free complete
protease inhibitors. Proteins were extracted and subjected to
sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) on a 10% gel. The bands were transferred to
a polyvinylidene difluoride membrane. After blocking with
5% nonfat dry milk in Tris-buffered saline supplemented
with 0.1% Tween 20 for 4 h at room temperature, the mem-
branes were incubated overnight at 4∘C with the following
antibodies: TLR2, TLR4, and ROR𝛾t (Abcam Inc., USA) and
FOXP3 (Abcam Inc., USA) primary antibodies (all used at
1 : 1000 dilution). The membranes were then incubated with
a secondary antibody at 37∘C for 1 h. Normalization was
performed by blotting the samemembraneswith anti-𝛽-actin
antibody (Abcam Inc., USA).
2.11. Statistical Analysis. All data were presented as the mean
± SD and evaluated by one-wayANOVAperformed using the
software SPSS version 12.0 (SPSS Inc., Chicago, IL, USA). For
𝑃 < 0.05, it will be regarded as statistically significant.
3. Results
3.1. Both Electroacupuncture and Moxibustion Generate Ther-
apeutic Effects on UC Mice Model. The DSS-induced UC
model mice generally were in poor conditions. Their hairs
were sparse and had no luster; their excrement was soft
and loose; the bloody excrement could be observed with
naked eyes; and the DAI scores increased significantly. After
the treatment of electroacupuncture and moxibustion, the
vitality of mice and several symptoms such as mucopurulent
stool, diarrhea, and other severe parameters have improved
significantly (𝑃 < 0.05). Consequently, the DAI score has
decreased significantly (𝑃 < 0.05) (Table 2).
Histopathology analysis showed that, for control group,
there were normal mucosal epithelia, intestinal glands, and
structure in distal colonic tissues. No signs of obvious
ulceration or inflammatory cell infiltration were observed.
In contrast, colonic tissues of rats from model group pre-
sented damaged mucosa, disordered glandular structure,
and inflammatory cells infiltration. After electroacupuncture
and moxibustion treatment, the histopathological conditions
have been improved in different levels: the epithelial mucosa
and glands are ordered andmost of the infiltrating inflamma-
tory cells have disappeared (Figure 1).
The ultrastructure inspection of the distal colon by
electron microscopy indicates that much more shortened
loose microvilli and large intraepithelial vacuoles were seen
in the model group. However, more good order microvilli,
normal mitochondria, and tight intracellular junctions are
found in the electroacupuncture and moxibustion treated
group (Figure 2).
The immunohistochemical result has shown that in the
model group the expressions of TLR2 and TLR4 were
facilitated.The immunohistochemicalmarkswhich indicated
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Table 2: Comparison of DAI in each group (means ± SD).
Group Sample After modeling After treatment
Control group — — —
Model group 12 2.67 ± 0.49 2.61 ± 0.51
EA-group 12 2.64 ± 0.52 1.11 ± 0.59∗
Moxibustion group 12 2.61 ± 0.44 1.05 ± 0.49∗
Note. ∗Compared with model group (𝑃 < 0.05).
∗
100 Ｇ
(a)
#
100 Ｇ
∇
(b)
100 Ｇ
(c)
100 Ｇ
(d)
Figure 1: HE staining results of distal colonic tissues in different group. Normal mucosal epithelia, intestinal glands, and structure were seen
in distal colonic tissues in the control group (a). Damaged mucosa, disordered glandular structure, and apparent edema in and underneath
the mucosa were found in the DSS-induced model group mice (b). And the histopathological conditions have been greatly improved in
acupuncture (c) andmoxibustion group (d) (∗normal architecture and lack of cellular infiltrate; #histological damage; ∇Globlet cell depletion;
magnification, 200x, and scale bar = 100 𝜇m).
the TLR2 protein and TLR4 protein in the model group
obviously have increased as compared to that of the control
group. Moreover, the marks have faded after either elec-
troacupuncture or moxibustion treatment, which indicates
that in both electroacupuncture and moxibustion groups
their expressions have been reduced (Figure 3). Semiquanti-
tative analysis showed that the relative optical density (OD)
of TLR2 and TLR4 in the model group was much higher
(compared with control group, 𝑃 < 0.01). However, after
acupuncture and moxibustion treatment, the relative OD
values are both decreased (compared with model group, 𝑃 <
0.01). As to the two treatment groups, moxibustion group has
a relative lower level and is more close to the control group
level (compared with electroacupuncture group, 𝑃 < 0.05).
Moreover, the results of western blot analysis (Figure 4) have
also shown that the TLR2 and TLR4 protein expressions of
the distal colon in model group are significantly enhanced,
while, after electroacupuncture and moxibustion treatment,
these two proteins have been significantly reduced (𝑃 < 0.01).
In addition, the protein expression of TLR2 in moxibustion
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Figure 2: The ultrastructure inspection of the distal colon tissues by electron microscopy. Compared with the control group (a), the model
group (b) has shown shortened loose microvilli with uneven length (M), large intraepithelial vacuoles (V), and unclear dissolved mucosal
granules in the cytoplasm. After acupuncture (c) or moxibustion (d) treatment, the microvilli are in good order (magnification, 10000x, and
scale bar = 2 𝜇m).
group is less than that in electroacupuncture group (𝑃 <
0.05), which indicated the effect of moxibustion was a little
bit better than electroacupuncture.
3.2. Electroacupuncture and Moxibustion Enhance the Bal-
ance of Treg/Th17 Axis. Compared with the control group,
CD4+CD25+Foxp3+Treg cells in spleen are significantly
decreased, and CD3+CD8+IL-17+Th17 cells are also sig-
nificantly increased (𝑃 < 0.05) in the UC model
mice. After electroacupuncture and moxibustion treatment,
CD4+CD25+Foxp3+Treg cells are significantly increased,
and CD3+CD8+IL-17+Th17 cells are significantly decreased
(𝑃 < 0.05). However, there is no obvious difference between
electroacupuncture group andmoxibustion group (𝑃 > 0.05)
(Figure 5).
3.3. Electroacupuncture and Moxibustion Improve Key
Immune FactorsThat Are Regulated by Treg/Th17 Axis. There
are also significant changes in the quantity of immune factors
in the model group. The levels of anti-inflammatory factors
including TGF-𝛽, IL-10, and IL-2 have significantly decreased
as compared to that of the control group (𝑃 < 0.01). On
the contrary, the levels of proinflammatory factors including
IL-6, IL-17A, and IL-17F have significantly increased after
modeling. Moreover, the changes in these immune factors
have greatly reverted after either electroacupuncture or
moxibustion treatment. The quantification analysis of these
immune factors indicates that the quantities of TGF-𝛽, IL-10,
and IL-2 have significantly increased in electroacupuncture
group (𝑃 < 0.01) and moxibustion group (𝑃 < 0.01).
Similarly, the levels of IL-6, IL-17A, and IL-17F have
significantly been reduced after treatment (𝑃 < 0.01 for IL-6
and 𝑃 < 0.05 for IL-17A and IL-17F). However, there is no
obvious difference between electroacupuncture group and
moxibustion group (𝑃 > 0.05) (Figure 6).
3.4. Electroacupuncture and Moxibustion Might Rebalance
the Treg/Th17 Axis through Regulating the Activity of Upper
Stream Proteins. Results of western blot analysis (Figure 7)
have shown that in model group the ROR𝛾t protein expres-
sion of the distal colon is enhanced, while that of the FOXP3
protein is weakened as compared with that of the control
group. Electroacupuncture andmoxibustion treatments have
significantly improved the expressions of these two important
proteins that were in the upper stream of the Treg/Th17 axis.
Compared with model group, the expression of the ROR𝛾t
protein is significantly reduced in electroacupuncture and
moxibustion groups (𝑃 < 0.01). As to the FOXP3 protein, its
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Figure 3: Toll-like receptor (TLR) 2 and TLR4 were detected in the colon by the immunohistochemical method. Compared with the control
group (a, e), the intestinal TLR2 and TLR4 expression in normal inmodel group have increased (b, f). After acupuncture (c, g) ormoxibustion
(d, h) treatment, the expressions of TLR2 and TLR4 have been reduced. The average IOD was obtained by analyzing TLR2 (i) and TLR4 (j)
immunohistochemistry staining in five random fields of each slide. Compared with electroacupuncture group, the OD level of TLR2 and
TLR4 in moxibustion group is lower. ∗𝑃 < 0.05; ∗∗𝑃 < 0.01 (magnification, 200x, and scale bar = 100𝜇m).
expression is significantly upregulated in electroacupuncture
and moxibustion groups when compared with that of the
model group (𝑃 < 0.01) (Figure 7). Compared with elec-
troacupuncture group, the protein expression of FOXP3 in
moxibustion group is higher than electroacupuncture group.
4. Discussions
The current study intends primarily to assess the effects
of electroacupuncture and moxibustion in managing UC
symptoms. Results have shown that both of these therapeutics
can significantly improve the symptoms ofUC as indicated by
the measurement of DAI which is adopted in most clinical
[25] and animal researches [26]. Further comparison has
also indicated that both electroacupuncture andmoxibustion
may regulate the intestinal immune response mediated by
rebalancing the Treg/Th17 axis [27]. Actually, this is the key
to both the development of UC and its successful treatment.
This study has also provided some evidences that moxibus-
tion may be better than electroacupuncture in alleviating UC
based on the protein expression of TLR2 and TLR4. Also,
moxibustion has better effect in increasing the level of FOXP3
protein. However, whether this effect is related to Treg/Th17
balance has not been clear yet because the cytokines and
the ROR𝛾t protein expression are not so convincing. These
results provided new clues for investigating and discussing
Evidence-Based Complementary and Alternative Medicine 7
Control Model Moxibustion Acupuncture
TLR2
TLR4
-Actin
95 ＋＄
100 ＋＄
43＋＄
0
0.2
0.4
0.6
0.8
1.0
1.2
Re
lat
iv
e T
LR
4 
pr
ot
ei
n 
le
ve
l
0
0.2
0.4
0.6
0.8
1.0
1.2
Re
lat
iv
e T
LR
2 
pr
ot
ei
n 
le
ve
l
∗
∗∗
∗∗
∗∗
∗∗ ∗∗
∗∗
Model Moxibustion AcupunctureControl Model Moxibustion AcupunctureControl
Figure 4: The protein expressions of TLR2 and TLR4 in the distal colon tissues. The results showed that the TLR2 and TLR4 protein
expressions of the distal colon in model group were significantly enhanced, while, after acupuncture and moxibustion treatments, these two
proteinswere significantly reduced (𝑃 < 0.01). In addition, the level of TLR2 inmoxibustion group is lower than that in the electroacupuncture
group. ∗𝑃 < 0.05; ∗∗𝑃 < 0.01.
the different mechanism of acupuncture and moxibustion in
treatingUC.More detailed discussions of the aforementioned
viewpoints are described as follows.
4.1. Treg/Th17 Balance Has a Crucial Impact on UC. It is
well known that there are many factors involved in the
pathogenesis of UC. One of the main causes is believed to
be the involvement of a dysregulated immune response to
some unknown stimulus [28]. Th17/Treg balance may play a
crucial role in this inflammatory and immunological process
of UC [8]. Due to the imbalance of Th17 and Treg, serum
concentrations of Th17-related cytokines (IL-6, IL-17A, and
IL-17F) will increase and Treg-related cytokines (IL-10, IL-
2, and TGF-𝛽) will decrease accordingly [29]. In addition,
the cytokines can exert synergistic effects in stimulating the
injury of colonic epithelial cells, which will then contribute
to the formation of local tissue inflammation. Recovery of
the Th17/Treg immune balance may imply new therapeutic
targets in UCmanagement [27]. FOXP3 is a master regulator
for the development and function of Treg cells. As a transcrip-
tion factor of Treg cells, it is crucial for the induction and
maintenance of the unique immune-suppressive properties
of Treg cells [30]. Mutations within the FOXP3 gene or
deletion of FOXP3 in transgenic mouse models can result
in the development of fatal autoimmunity. ROR𝛾t innate
lymphoid cells play a fundamental role in the development
of lymphoid tissues, as well as in homeostasis and defense of
mucosal tissues [31]. These cells produce key cytokines, IL-
22 and IL-17A, for the activation of epithelial defenses and
the recruitment of polymorphonuclear phagocytes. In the
absence of ROR𝛾t innate lymphoid cells, the early defense to
infection and resistance to injury are compromised.
A number of studies have shown that inflammation
cytokines or inflammatory protein was responsible for UC
inflammation [32, 33]. Besides, many studies showed that,
in the absence of TLR stimuli, Tregs dampened B cell
proliferation, plasma cell formation, and Ig production [34].
What is more, TLR2 stimulation drives human naive and
effectors regulatory T cells into a Th17-like phenotype with
reduced suppressive function and regulates the balance
between regulatory T cell andTh17 function [35, 36], thereby
promoting disease activity and progression. In this study, we
revealed that the trends of serum IL-10, IL-2, IL-6, IL-17A,
and IL-17F in DSS-induced UC mice coincide with previous
reports. In addition, the levels of protein expressions of TLR2
andTLR4 in intestinal tissues get the similar results too.Thus,
the aforementioned results have provided further and relative
comprehensive evidences for the importance of evaluating
the levels of Th17/Treg axis in UC development. So far, our
results have demonstrated that the balance of peripheral
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Figure 5: Flow cytometric pictures and the percentage of CD4+CD25+Foxp3+Treg cells and CD3+CD8+IL-17+Th17 cells among CD4+T
cells in each group. Lymphocytes from spleen of each group were stained with labeled as anti-mice antibodies as in the described
methods. Treg cells and Th17 were gated and shown in the right-upper quadrant. Compared with control group, the percentage of Treg
(CD4+CD25+Foxp3+Treg/CD4+ T cells) in model group decreased (𝑃 < 0.05). Treg cells content increased after acupuncture or moxibustion
treatment (𝑃 < 0.05). On the contrary, the percentage of Th17 cells significantly increased (𝑃 < 0.05) in UC model mice while decreasing by
both acupuncture and moxibustion. ∗𝑃 < 0.05.
Treg/Th17 is disturbed in UC mice, and the Treg/Th17
imbalance might act synergistically with microinflammation
on the development of UC. Concurrently, our data have also
shown a reciprocal relationship between Treg and Th17 cells
numbers, as well as between Treg andTh17-related cytokines.
These results indicate that the Treg/Th17 immune axis may
be involved in the mechanism of UC progression and the
functional imbalance of Treg/Th17 may have a potential
impact on it.
4.2. Electroacupuncture and Moxibustion Can Ameliorate
the Balance of Treg/Th17 in UC Mice. Currently, patients
with inflammatory bowel disease (IBD) or irritable bowel
syndrome (IBS) have either very few effective treatments or
some modestly effective treatments which are not entirely
free from risks. Thus, seeking safe and effective treatments
for these diseases has been imperative. Moxibustion and
electroacupuncture, although their effects should be further
improved by rigorously designed clinical trials, have gained
much attention as alternative and complementary therapeu-
tic interventions due to their relatively low clinical side effects
as compared to drug therapy or surgical procedures [37–
39]. When moxibustion is added as an adjunct to other
treatments, it significantly reduces symptoms of IBD or
IBS relative to other treatments alone. Joos et al. [38] have
suggested that acupuncture offers an additional therapeutic
benefit in patients with mild to moderately active UC.
Most researches have focused on whether moxibustion
and acupuncture are effective, and very few have inves-
tigated the mechanistic connection between moxibustion
and acupuncture therapy. Wu et al. [40] have suggested
that moxibustion and acupuncture inhibited expression of
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Figure 6: Quantification of the key immune factors by ELISA test: TNF-𝛽, IL-10, and IL-2; IL-6, IL-17A, and IL-17F. The results showed that
the levels of anti-inflammatory factors including TGF-𝛽, IL-10, and IL-2 in the UC model group significantly decreased (Figure 6, upper
panel; as compared with control group 𝑃 < 0.01). On the contrary, the levels of proinflammatory factors including IL-6, IL-17A, and IL-17F
significantly increased after modeling (Figure 6, lower panel; as compared with control group 𝑃 < 0.01). After acupuncture and moxibustion
treatments, the levels of TGF-𝛽, IL-10, and IL-2 were significantly increased (Figure 6, upper panel) and the levels of IL-6, IL-17A, and IL-17F
were significantly reduced (lower panel). In addition, there is no obvious difference between them in all these inflammation factors. ∗𝑃 < 0.05;
∗∗
𝑃 < 0.01.
inflammatory cytokines by observing IL-1𝛽 and IL-6 mRNA
expression in the spleen and colonic mucosa of UC rats. In
Han’s study [26], moxibustion treatment improves disease
activity, repairs damaged colonic mucosa, and suppresses
secretion of serum IL-8 while it activates that of IL-10,
inhibits activation of NF-𝜅B p65, and decreases expression
of TLR-9 in UC rats [26]. In our study, results indicate
that both electroacupuncture andmoxibustion treatment can
improve disease activity, repair damaged colonic mucosa,
decrease the protein expression of TLR2 and TLR4, increase
the content of CD4+CD25+Foxp3+ Treg cells, and decrease
the level of CD3+CD8+IL-17+Th17 cells. In addition, after
electroacupuncture and moxibustion treatment, the levels
of TGF-𝛽, IL-10, and IL-2 have significantly increased and
the levels of IL-6, IL-17A, and IL-17F have significantly
reduced, indicating electroacupuncture andmoxibustion can
inhibit the inflammatory cells by suppressing secretion of
proinflammatory cytokine and activate secretion of anti-
inflammatory cytokine. To further verify the proposed idea
that the effects of electroacupuncture and moxibustion ther-
apy in UC mice are probably related to Th17/Treg immune
axis, we have detected the protein expressions of FOXP3
and ROR𝛾t. The results have shown that the ROR𝛾t expres-
sion has significantly increased and FOXp3 expression has
significantly decreased in the UC model mice, but after
either electroacupuncture or moxibustion treatment, ROR𝛾t
expression has obviously decreased and FOXP3 expression
has increased almost to the normal level, indicating that both
electroacupuncture and moxibustion therapies can maintain
the equilibrium of Th17/Treg immune axis in UC mice.
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Figure 7: The protein expressions of ROR𝛾t and FOXP3 in the distal colon tissues. Compared with controls, the ROR𝛾t expression was
significantly increased and FOXp3+ expression was significantly decreased in the UCmodel group (𝑃 < 0.01). However, after acupuncture or
moxibustion treatment, ROR𝛾t expression was obviously decreased (𝑃 < 0.01) and FOXP3 expression was increased (𝑃 < 0.01). In addition,
moxibustion increased higher FOXP3 than electroacupuncture. ∗𝑃 < 0.05; ∗∗𝑃 < 0.01.
4.3. To Some Extent, Moxibustion Has Better Efficacy Than
Electroacupuncture in Treating UC, but Its Relationship to
Treg/Th17 Axis Is Not Clear Yet. There is an increasing
number of clinical studies of electroacupuncture and mox-
ibustion treatments for IBD [41, 42] and IBS [43], and
the existing investigations have partially demonstrated that
electroacupuncture and moxibustion can effectively control
bowel inflammation by providingmultitargeted regulation of
the body’s physiological balance. However, it is imperative to
know if there is actually any difference between these two
treatments in activating acupoints and treating UC. A system
review [42] has indicated that, among the 43 included RCT
studies, acupuncture and moxibustion therapies were alter-
natively used in 17 studies [44–60]; moxibustion treatment
was used as the main intervention in 12 studies [44–53, 58,
59], while acupuncture alone was used in one study [60];
combinations of two types of acupuncture and moxibustion
treatments were used in 10 studies [38, 61–69]. Other studies
combined acupuncture, moxibustion, and traditional Chi-
nese herb or cupping or other methods [70–75]. According
to this review, moxibustion has been more widely used
in treating UC, but no study has explicitly indicated the
difference and the reason why acupuncture is not widely
used as moxibustion. In the current study, we have found
that, at least to some extent, moxibustion demonstrates better
efficacy than acupuncture. For example, in ameliorating the
level of TLR2 and TLR4 (we mentioned above that they
are closely related to intestinal inflammation), the effect of
moxibustion is better than that of electroacupuncture (𝑃 <
0.05). In addition, moxibustion can obviously improve the
protein level of FOXP3 (𝑃 < 0.05). However, based on our
results, whether the better curative effect of moxibustion is
related to Treg/Th17 balance has not been clear yet. For one
thing, the percentage of CD4+CD25+Foxp3+Treg cells and
CD3+CD8+IL-17+Th17 cells among CD4+T cells in the two
treatment groups has no obvious difference (𝑃 > 0.05). For
another, the cytokines of IL-10, IL-2, IL-6, IL-17A, and IL-
17F and the protein expression of ROR𝛾t have no difference
either. Further study should be carried out to prove that.
In summary, this study proved that both electroacupunc-
ture and moxibustion can ameliorate UC and their effects are
partially from the way of improving the balance ofTh17/Treg.
In addition, our study indicated whether moxibustion has
better efficacy than electroacupuncture needs further study.
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